寶萊特(300246.SZ)2022年度淨利潤預降60.81%至73.35%
格隆匯1月31日丨寶萊特(300246.SZ)公佈,預計2022年度歸屬於上市公司股東的淨利潤1700萬元-2500萬元,同比下降60.81%至73.35%;扣除非經常性損益後的淨利潤170萬元-250萬元,同比下降94.34%至96.15%。
2022年預計非經常性損益對公司淨利潤的影響金額約1955.64萬元。
報吿期內,儘管遭遇各種不利因素影響,但通過多方努力,尤其是產品力的增強及客户結構優化,公司營業收入同比依然保持增長;受物流成本上升、原材料價格上漲、銷售費用大幅增加以及研發投入加大等影響,歸屬於上市公司股東的淨利潤同比下降。
2023年,公司將加強經營管理,把握住醫療器械國產替代進口、各級醫院升級改造建設的重大機遇,並堅定以“重症先鋒、腎科龍頭”為發展定位,將通過持續加大技術研發力度提升公司產品競爭力、品牌影響力,通過供應鏈管理、產能和物流運輸優化,並充分發揮全國多基地佈局的優勢,實現主營業務增長,實現效率、效益雙提升,推動公司持續健康發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.